Charu Aggarwal, MD, MPH

home / authors / charu-aggarwal-md-mph

Articles

IMpower 133 Trial and Patient Selection for Durvalumab + Chemotherapy vs Atezolizumab + Chemotherapy

Charu Aggarwal, MD, MPH;Taofeek K. Owonikoko, MD, PhD;Charles M. Rudin, MD, PhD;Vivek Subbiah, MD;Jared Weiss, MD

July 18th 2022

Dr Charu Aggarwal shares data from the IMpower133 trial of atezolizumab plus chemotherapy for SCLC, and how to select the appropriate frontline therapy.

Management of Adverse Events Associated with Durvalumab + Chemotherapy

Charu Aggarwal, MD, MPH;Taofeek K. Owonikoko, MD, PhD;Charles M. Rudin, MD;Vivek Subbiah, MD;Jared Weiss, MD

July 11th 2022

Vivek Subbiah, MD, analyzes adverse events observed with durvalumab plus chemotherapy in patients with SCLC and how they can be managed.

Frontline Therapy for SCLC: The CASPIAN Trial of Durvalumab + Chemotherapy

Taofeek K. Owonikoko, MD, PhD;Charu Aggarwal, MD, MPH;Charles M. Rudin, MD, PhD;Vivek Subbiah, MD;Jared Weiss, MD

July 11th 2022

Jared Weiss, MD, reviews data from the CASPIAN trial of durvalumab plus chemotherapy in patients with extensive-stage small cell lung cancer.

Patient Profile 1: A 68-Year-Old Male with SCLC and Brain Metastases

Charu Aggarwal, MD, MPH;Taofeek K. Owonikoko, MD, PhD;Charles M. Rudin, MD, PhD;Vivek Subbiah, MD;Jared Weiss, MD

July 6th 2022

Charu Aggarwal, MD, MPH, presents the profile of a patient with small cell lung cancer with brain metastases to spark a discussion on treatment approaches in the frontline setting.

Progress in the Treatment and Management of SCLC

Charu Aggarwal, MD, MPH;Taofeek K. Owonikoko, MD, PhD;Charles M. Rudin, MD, PhD;Vivek Subbiah, MD;Jared Weiss, MD

July 6th 2022

The panel discusses how the field of small cell lung cancer treatment has changed in recent years.

Use of the TNM Staging System in SCLC

Charu Aggarwal, MD, MPH;Taofeek K. Owonikoko, MD, PhD;Charles M. Rudin, MD, PhD;Vivek Subbiah, MD;Jared Weiss, MD

June 27th 2022

Charles Rudin, MD, PhD, explains the prognostic staging systems used for small cell lung cancer.

close-up of Taofeek Owonikoko, MD, PhD, and Vivek Subbiah, MD, smiling at camera

Overview of SCLC and Importance of Early Diagnosis

Charu Aggarwal, MD, MPH;Taofeek K. Owonikoko, MD, PhD;Charles M. Rudin, MD, PhD;Vivek Subbiah, MD;Jared Weiss, MD

June 27th 2022

Drs Owonikoko and Weiss provide a brief overview of small cell lung cancer and the vital importance of an early diagnosis to improve patient outcomes.

<1 2